Extracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Dual leads to higher extracranial haemorrhage compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Intracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Multiple may leads to higher intracranial haemorrhage compared with fewer antiplatelet agents (low certainty).
1 finding from 1 review
Extracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Multiple leads to higher extracranial haemorrhage compared with fewer antiplatelet agents (high certainty).
1 finding from 1 review
Intervention not reported
Intracranial haemorrhages · people with atrial fibrillation deemed eligible for long‐term anticoagulant treatment
The intervention leads to lower intracranial haemorrhages (high certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage at
Percutaneous vascular interventions showed no clear difference in symptomatic intracranial haemorrhage within first 14 days compared with intravenous thrombolytic treatment (low certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage/haemorrhagic transformation of the cerebral infarct during treatment period (range 6 days to 16 days)⁹ · acute ischaemic stroke
Low‐molecular‐weight heparins or heparinoids showed no clear difference in symptomatic intracranial haemorrhage/haemorrhagic transformation of… compared with unfractionated heparin (low certainty).
1 finding from 1 review
Intervention not reported
Quality of life: Stroke Impact Scale (SIS) SIS measures quality of life across five domains: physical (strength, hand‐function, mobility, activities of daily living), emotion, memory, communication, social participation, plus 1 global question abo... · adults with stroke
1 finding from 1 review
Intervention not reported
Quality of life: Stroke‐specific QoL Scale (SS QoL) The Stroke‐specific QoL Scale measures quality of life across 12 domains (49 items): self‐care, vision, language, mobility, work, upper extremity, thinking, personality, mood, family, social, and... · adults with stroke
1 finding from 1 review
Death or stroke · people with symptomatic intracranial artery stenosis
Endovascular therapy plus conventional medical treatment probably leads to higher death or stroke compared with conventional medical treatment alone (moderate certainty).
1 finding from 1 review
Long‐term ipsilateral stroke · people with symptomatic intracranial artery stenosis
Endovascular therapy plus conventional medical treatment probably leads to higher ipsilateral stroke compared with conventional medical treatment alone (moderate certainty).
1 finding from 1 review
Type of recurrent event · people with symptomatic intracranial artery stenosis
Endovascular therapy plus conventional medical treatment showed no clear difference in type of recurrent event compared with conventional medical treatment alone (moderate certainty).
1 finding from 1 review
Death · people with symptomatic intracranial artery stenosis
Endovascular therapy plus conventional medical treatment may leads to higher death compared with conventional medical treatment alone (low certainty).
1 finding from 1 review
Dependency · people with symptomatic intracranial artery stenosis
Endovascular therapy plus conventional medical treatment showed no clear difference in dependency compared with conventional medical treatment alone (moderate certainty).
1 finding from 1 review
Restenosis (≥ 50%) · people with symptomatic intracranial artery stenosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · people with symptomatic intracranial artery stenosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Morbidity (GOS) · people with unruptured intracranial aneurysms
1 finding from 1 review
Death · people with unruptured intracranial aneurysms
1 finding from 1 review
Stroke · people with unruptured intracranial aneurysms
1 finding from 1 review
Infection rate Short term (0 to 30 days) · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection rate Long term (30 to 365 days) · people with unruptured intracranial aneurysms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found